Back to Jefferies Financial Group Inc. Jefferies Financial Group Inc.

URGN

Showing 9 of 11 quarters

Position history for Jefferies Financial Group Inc.Jefferies Financial Group Inc.'s holdings in UroGen Pharma Ltd.

Yes. Jefferies Financial Group holds 2,199,652 shares of URGN (UroGen Pharma), worth $89.4M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Jefferies Financial Group has held URGN since Q1 2024, across 11 quarterly 13F filings. URGN is 0.7% of Jefferies Financial Group's reported 13F portfolio.

Current Value

$89.4M

Current Shares

2.2M

Total Value Change

+$77.1M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
2.2M
0.0%
$89.4M0.7%$40.63
0
2026-Q2
Unchanged
2.2M
0.0%
$80.9M0.5%$36.80
0
2026-Q1
Unchanged
2.2M
0.0%
$39.5M0.3%$17.98
0
2025-Q4
Unchanged
2.2M
0.0%
$51.5M0.3%$23.42
0
2025-Q3
Unchanged
2.2M
0.0%
$43.9M0.2%$19.95
0
2025-Q2
Increased
2.2M
+169.9%
$30.1M0.3%$13.70
56
2025-Q1
Decreased
815,000
-15.6%
$9M0.1%$11.06
0
2024-Q4
Increased
965,929
+0.1%
$10.3M0.1%$10.65
28
2024-Q3
Unchanged
965,000
0.0%
$12.3M0.1%$12.70
0

Other major holders of URGN: RTW Investments, LP, BlackRock, Inc., Menora Mivtachim Holdings Ltd.

Optional analytics helps us improve. How it’s used